Abivax S.a.

This study tested whether a daily pill called ABX464 could help people with moderate to severe ulcerative colitis who haven't responded well to other treatments. Researchers compared the pill against a placebo in 639 participants over 8 weeks to see if it could reduce symptoms an…

This study tested a daily pill called ABX464 to see if it could safely keep ulcerative colitis under control over a long period. It involved 217 people with moderate to severe disease who had already taken the drug in a previous short-term study. The main goal was to see how many…

This study tested whether a daily pill called ABX464 could help control moderate-to-severe ulcerative colitis in people who haven't gotten enough relief from standard treatments. Researchers compared the pill to a placebo (inactive pill) in 636 participants over 8 weeks to see if…

This study followed 40 patients with moderate to severe rheumatoid arthritis for up to two years to see if the oral medication ABX464 remains safe and effective over time. All participants received the same daily dose of the drug, regardless of whether they received the real medi…

This study tested a new daily pill called ABX464 for people with moderate-to-severe ulcerative colitis who haven't gotten better with standard treatments. It involved 355 patients who took one of three different doses or a placebo pill for 16 weeks. The main goal was to see if th…